Safranal, a Natural Neuroprotective Compound, Modulates Plasma Iron Levels, Improves Behavioral Performance, and Demonstrates Dose-Specific Cytoprotection in Alzheimer’s Disease Models
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27209392 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Esra Tekin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Medicine, Kırıkkale University, 71450 Kırıkkale, Türkiye. Hauptthemen laut MEDLINE: Alzheimer Disease, Neuroprotective Agents, Iron, Cyclohexenes. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Scientific and Technological Research Council of Türkiye, Scientific and Technological Research Council of Türkiye.
Themen: Demenz
Abstract (Originalsprache)
Metal dyshomeostasis contributes to Alzheimer’s disease (AD) by influencing amyloid aggregation, oxidative imbalance, and impaired clearance mechanisms. Safranal, a bioactive constituent of Crocus sativus, exhibits antioxidant properties, but its metal-modulating actions remain insufficiently understood. This study investigated whether safranal modulates metal (Fe, Cu, Zn) levels in an AD rat model while evaluating its cytoprotective rescue capacity against Aβ1-42 induced neurotoxicity in differentiated SH-SY5Y cells. AD was induced in male rats via intracerebroventricular streptozotocin, followed by a four-week safranal administration (0.5 mg/kg/day, ip). Behavioral performance, plasma metal levels (ICP-MS), and cerebral total antioxidant capacity (FRAP) were evaluated alongside histological assessment. Post-treatment protocols were employed to evaluate the effects of safranal on cell viability and apoptosis in differentiated SH-SY5Y cells exposed to Aβ1-42. Longitudinal analyses revealed that safranal attenuated exploratory deficits and recognition memory impairments in AD rats. Decreased plasma iron levels in the AD group were restored by safranal, accompanied by a return of cerebral antioxidant capacity to normal. Although overt hippocampal histological alterations were absent in this early phase, post-treatment with safranal successfully offered a therapeutic rescue window, preserving cell viability and attenuating Aβ1-42-induced apoptotic features in vitro. Safranal demonstrates beneficial neuroprotective effects in AD models by improving behavioral outcomes, partially correcting plasma iron levels, and mediating cytoprotective rescue windows against Aβ1-42-induced cellular toxicity. These findings suggest that safranal represents a promising natural candidate for reducing behavioral deficits, supporting peripheral iron status, and offering functional cell survival in AD models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Faculty of Medicine, Kırıkkale University, 71450 Kırıkkale, Türkiye.
- Department of Engineering Basic Sciences, Faculty of Engineering and Natural Sciences, Kutahya Health Sciences University, 43100 Kutahya, Türkiye.
- Department of Histology and Embryology, Faculty of Medicine, Gazi University, 06500 Ankara, Türkiye.
- Neuroscience and Neurotechnology Center of Excellence (NÖROM), Gazi University, 06560 Ankara, Türkiye.
- Department of Medical Services and Techniques, School of Health Services, Gazi University, 06830 Ankara, Türkiye.
- Life Sciences Application and Research Center, Gazi University, 06830 Ankara, Türkiye.
ORCID-Profile: Meliha Koldemir Gündüz
Förderung
- The Scientific and Technological Research Council of Türkiye
- Scientific and Technological Research Council of Türkiye
Zitieren
APA
Tekin, E., Koldemir Gündüz, M., Yığman, Z., Aydoğan Kara, B., Küçük, A., & Arslan, M. (2026). Safranal, a Natural Neuroprotective Compound, Modulates Plasma Iron Levels, Improves Behavioral Performance, and Demonstrates Dose-Specific Cytoprotection in Alzheimer’s Disease Models. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27209392
Vancouver
Tekin E, Koldemir Gündüz M, Yığman Z, Aydoğan Kara B, Küçük A, Arslan M. Safranal, a Natural Neuroprotective Compound, Modulates Plasma Iron Levels, Improves Behavioral Performance, and Demonstrates Dose-Specific Cytoprotection in Alzheimer’s Disease Models. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27209392
BibTeX
@article{Tekin2026,
author = {Tekin, Esra and Koldemir Gündüz, Meliha and Yığman, Zeynep and Aydoğan Kara, Beyza and Küçük, Ayşegül and Arslan, Mustafa},
title = {Safranal, a Natural Neuroprotective Compound, Modulates Plasma Iron Levels, Improves Behavioral Performance, and Demonstrates Dose-Specific Cytoprotection in Alzheimer’s Disease Models},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27209392}
}
EUVIMED